Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Conditions
Immune-Related Adverse Events · Lupus Erythematosus, Systemic · Sjogren Syndrome · Systemic Sclerosis (SSc) · Inflammatory Myopathies · Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Universitario de Navarra, Pamplona, Navarre, Spain